Biosimulation Technology Market Size, Trend, Segmentation, Growth And Opportunities Forecast To 2025
This report focuses on the global Biosimulation Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosimulation Technology development in United States, Europe and China.
Biosimulation techonlogy is a mathematical simulation of biological process in which computer aided programs are used for the simulation of biological processes and systems. It is also known as model-based drug development that has ability to make data-driven decisions at all stages of drug development through a quantitative framework. Biosimulation is a promising technology that especially used in pharmaceutical research to improve the drug discovery and development cycle of a drug.
In 2017, the global Biosimulation Technology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
The key players covered in this study
Certara USA
Simulation Plus
Dassault Systèmes
Schrodinger
Advanced Chemistry Development
Chemical Computing Group
Entelos
Genedata
Physiomics
Rhenovia Pharma
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3351454-global-biosimulation-technology-market-size-status-and-forecast-2018-2025
Market segment by Type, the product can be split into
Software
Service
Market segment by Application, split into
Drug development
Drug discovery
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Biosimulation Technology status, future forecast, growth opportunity, key market and key players.
To present the Biosimulation Technology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biosimulation Technology Market Size Growth Rate by Type (2013-2025)
1.4.2 Software
1.4.3 Service
1.5 Market by Application
1.5.1 Global Biosimulation Technology Market Share by Application (2013-2025)
1.5.2 Drug development
1.5.3 Drug discovery
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biosimulation Technology Market Size
2.2 Biosimulation Technology Growth Trends by Regions
2.2.1 Biosimulation Technology Market Size by Regions (2013-2025)
2.2.2 Biosimulation Technology Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Biosimulation Technology Market Size by Manufacturers
3.1.1 Global Biosimulation Technology Revenue by Manufacturers (2013-2018)
3.1.2 Global Biosimulation Technology Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Biosimulation Technology Market Concentration Ratio (CR5 and HHI)
3.2 Biosimulation Technology Key Players Head office and Area Served
3.3 Key Players Biosimulation Technology Product/Solution/Service
3.4 Date of Enter into Biosimulation Technology Market
3.5 Mergers & Acquisitions, Expansion Plans
................
12 International Players Profiles
12.1 Certara USA
12.1.1 Certara USA Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biosimulation Technology Introduction
12.1.4 Certara USA Revenue in Biosimulation Technology Business (2013-2018)
12.1.5 Certara USA Recent Development
12.2 Simulation Plus
12.2.1 Simulation Plus Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biosimulation Technology Introduction
12.2.4 Simulation Plus Revenue in Biosimulation Technology Business (2013-2018)
12.2.5 Simulation Plus Recent Development
12.3 Dassault Systèmes
12.3.1 Dassault Systèmes Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biosimulation Technology Introduction
12.3.4 Dassault Systèmes Revenue in Biosimulation Technology Business (2013-2018)
12.3.5 Dassault Systèmes Recent Development
12.4 Schrodinger
12.4.1 Schrodinger Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biosimulation Technology Introduction
12.4.4 Schrodinger Revenue in Biosimulation Technology Business (2013-2018)
12.4.5 Schrodinger Recent Development
12.5 Advanced Chemistry Development
12.5.1 Advanced Chemistry Development Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biosimulation Technology Introduction
12.5.4 Advanced Chemistry Development Revenue in Biosimulation Technology Business (2013-2018)
12.5.5 Advanced Chemistry Development Recent Development
12.6 Chemical Computing Group
12.6.1 Chemical Computing Group Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biosimulation Technology Introduction
12.6.4 Chemical Computing Group Revenue in Biosimulation Technology Business (2013-2018)
12.6.5 Chemical Computing Group Recent Development
12.7 Entelos
12.7.1 Entelos Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biosimulation Technology Introduction
12.7.4 Entelos Revenue in Biosimulation Technology Business (2013-2018)
12.7.5 Entelos Recent Development
12.8 Genedata
12.8.1 Genedata Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biosimulation Technology Introduction
12.8.4 Genedata Revenue in Biosimulation Technology Business (2013-2018)
12.8.5 Genedata Recent Development
12.9 Physiomics
12.9.1 Physiomics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biosimulation Technology Introduction
12.9.4 Physiomics Revenue in Biosimulation Technology Business (2013-2018)
12.9.5 Physiomics Recent Development
12.10 Rhenovia Pharma
12.10.1 Rhenovia Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biosimulation Technology Introduction
12.10.4 Rhenovia Pharma Revenue in Biosimulation Technology Business (2013-2018)
12.10.5 Rhenovia Pharma Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
……Continued
Access Complete Report @ https://www.wiseguyreports.com/reports/3351454-global-biosimulation-technology-market-size-status-and-forecast-2018-2025
Contact Us:
Norah Trent
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Monday August 27 2018, 3:46 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
